81 related articles for article (PubMed ID: 34940951)
1. The impact of short-course hypofractionated radiotherapy on multimodality treatment utilisation, compliance, and outcome in glioblastoma patients: a Danish patterns of care study.
Vamsi VS; Lukacova S; Dahlrot RH; Guldberg TL; Korshøj AR; Muhic A; Trip AK
Acta Oncol; 2023 Nov; 62(11):1511-1519. PubMed ID: 37558643
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenia is associated with chemoradiotherapy discontinuation and reduced progression-free survival in glioblastoma patients.
Troschel FM; Troschel BO; Kloss M; Jost J; Pepper NB; Völk-Troschel AS; Wiewrodt RG; Stummer W; Wiewrodt D; Eich HT
Strahlenther Onkol; 2024 Mar; ():. PubMed ID: 38546749
[TBL] [Abstract][Full Text] [Related]
3. Challenges of Using High-Dose Fractionation Radiotherapy in Combination Therapy.
Yang YC; Chiang CS
Front Oncol; 2016; 6():165. PubMed ID: 27446811
[TBL] [Abstract][Full Text] [Related]
4. Nocardia brain abscess mimicking tumor progression in an elderly glioblastoma patient treated with temozolomide radiochemotherapy.
Kourouma M; Joubert B; Berhouma M; Roux S; Meyronet D; Ducray F
Rev Neurol (Paris); 2023 Oct; 179(8):929-931. PubMed ID: 37625975
[No Abstract] [Full Text] [Related]
5. Hypofractionated versus standard radiation therapy in combination with temozolomide for glioblastoma in the elderly: a meta-analysis.
Lu VM; Kerezoudis P; Brown DA; Burns TC; Quinones-Hinojosa A; Chaichana KL
J Neurooncol; 2019 Jun; 143(2):177-185. PubMed ID: 30919157
[TBL] [Abstract][Full Text] [Related]
6. Hypofractionation in Glioblastoma: An Overview of Palliative, Definitive, and Exploratory Uses.
Jiang C; Mogilevsky C; Belal Z; Kurtz G; Alonso-Basanta M
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067354
[TBL] [Abstract][Full Text] [Related]
7. Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis.
Klement RJ; Popp I; Kaul D; Ehret F; Grosu AL; Polat B; Sweeney RA; Lewitzki V
J Neurooncol; 2022 Jan; 156(2):407-417. PubMed ID: 34940951
[TBL] [Abstract][Full Text] [Related]
8. Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma.
Lewitzki V; Klement RJ; Kosmala R; Lisowski D; Flentje M; Polat B
Radiat Oncol; 2019 Dec; 14(1):227. PubMed ID: 31831026
[TBL] [Abstract][Full Text] [Related]
9. Accelerated hyperfractionation plus temozolomide in glioblastoma.
Kaul D; Florange J; Badakhshi H; Grün A; Ghadjar P; Exner S; Budach V
Radiat Oncol; 2016 May; 11():70. PubMed ID: 27209069
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy plus temozolomide in elderly patients with glioblastoma: a "real-life" report.
Biau J; Chautard E; De Schlichting E; Dupic G; Pereira B; Fogli A; Müller-Barthélémy M; Dalloz P; Khalil T; Dillies AF; Durando X; Godfraind C; Verrelle P
Radiat Oncol; 2017 Dec; 12(1):197. PubMed ID: 29212499
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of hypofractionated radiotherapy (HFRT) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: A meta-analysis.
Guo L; Li X; Chen Y; Liu R; Ren C; Du S
Cancer Radiother; 2021 Apr; 25(2):182-190. PubMed ID: 33436285
[TBL] [Abstract][Full Text] [Related]
12. Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial).
Mallick S; Kunhiparambath H; Gupta S; Benson R; Sharma S; Laviraj MA; Upadhyay AD; Julka PK; Sharma D; Rath GK
J Neurooncol; 2018 Oct; 140(1):75-82. PubMed ID: 29936695
[TBL] [Abstract][Full Text] [Related]
13. Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial.
Voss M; Wenger KJ; von Mettenheim N; Bojunga J; Vetter M; Diehl B; Franz K; Gerlach R; Ronellenfitsch MW; Harter PN; Hattingen E; Steinbach JP; Rödel C; Rieger J
Eur J Nutr; 2022 Feb; 61(1):477-487. PubMed ID: 34487222
[TBL] [Abstract][Full Text] [Related]
14. Initial Results of a Phase 2 Trial of
Laack NN; Pafundi D; Anderson SK; Kaufmann T; Lowe V; Hunt C; Vogen D; Yan E; Sarkaria J; Brown P; Kizilbash S; Uhm J; Ruff M; Zakhary M; Zhang Y; Seaberg M; Wan Chan Tseung HS; Kabat B; Kemp B; Brinkmann D
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1383-1395. PubMed ID: 33771703
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
